California International STI Consortium (CISC)

The primary objective of the California-International Sexually Transmitted Infection (STI) Consortium (CISC) is to provide the infrastructure, capacity, and scientific leadership to design and conduct state-of-the-art intervention trials to prevent and treat STIs worldwide. CISC combines a multidisciplinary and multinational approach to our research.

Our consortium brings together many of the world’s leading researchers from some of the country’s most esteemed research and public health institutions. CISC combines expertise from California: the University of California San Francisco (UCSF) as the master contractor; San Francisco Department of Public Health (SFDPH); University of California Los Angeles (UCLA); Los Angeles Department of Health Services (LADHS); State of California Department of Health Services, STD Control Branch; and Stanford University; with international collaborating institutions in seven countries. Our International partners are divided into two tiers; Consortium Partners who will participate in the CISC Executive Committee and act as full subcontractors; and Consortium Collaborators who will expand CISC’s geographic reach and participate in clinical trials as deemed necessary.

CISC Consortium Partners include: Canada (University of Toronto (UT)); China (National Center for AIDS/STD Control and Prevention); Kenya (Kenya Medical Research Institute (KEMRI)) and the University of Nairobi (UN)); Zimbabwe (University of Zimbabwe (UZ)); and Mexico (National Institute of Public Health (INSP). CISC Collaborators include Brazil (Oswaldo Cruz Institute) and Viet Nam (Hanoi Medical University).